Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers.
We can observe trend reversal on Delcath. We've had clear impulsive wave up in June 2017, since then we are in clear ABC correction. Correction should end around 4-5cents and around end-of-September. Following rise should be a huge impulsive wave C or wave 3 which will take us to $1-$1.3 level.
Hello everyone Here is my analysis on the DCTH stock. For me it looks very bullish because of the ascending triangle. As I think we will reach new All time highs soon! Dont forget all the news, and the thing that people say they maybe get delisted. I don't think so, I think their drug will get FDA approved. Please do also your own DD. Thanks :)
Reposting as it didn't post properly the first time $DCTH Highlights for the first quarter of 2017 and the recent weeks include: First quarter 2017 revenue of $0.74 million, an increase of 100% compared with revenue of $0.37 million in prior year quarter. CHEMOSAT treatment milestone set by SPIRE Southampton Hospital in the U.K. with more than 100 CHEMOSAT...
here is my estimate for $DCTH to get to 1.00 using RENKO and WAVES, remember, RENKO ignores time, so this chart does not mean it will reach 1.00 by 6/29
See chart Good media news on it today REMEMBER it's a Biotech... Highly volatile !!!! Haven't got the time right now for more comments Follow me on twitter for quicker updates Fear not trade what you see @BLawrenceM